Skip to main content
Clinical Trials/IRCT20210308050634N1
IRCT20210308050634N1
Recruiting
Phase 3

Comparison of the effectiveness of proton pump inhibitor (PPI) alone and with the method of adding baclofen to proton pump inhibitor (PPI) in the treatment of patients with gastroesophageal reflux disease (GERD) aged 7 to 12 years

Islamic Azad University0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
gastroesophageal reflux disease.
Sponsor
Islamic Azad University
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children 7\-12 years with gastroesophageal reflux disease

Exclusion Criteria

  • Cases of specific diseases (cerebral palsy, treated with anticonvulsant drugs, patients with gastrointestinal ulcers and IBD)

Outcomes

Primary Outcomes

Not specified

Similar Trials